1. Home
  2. CADL vs RYAM Comparison

CADL vs RYAM Comparison

Compare CADL & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.56

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Logo Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc.

HOLD

Current Price

$8.56

Market Cap

661.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
RYAM
Founded
1999
1926
Country
United States
United States
Employees
N/A
2325
Industry
Biotechnology: Pharmaceutical Preparations
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
578.8M
661.8M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
CADL
RYAM
Price
$8.56
$8.56
Analyst Decision
Strong Buy
Buy
Analyst Count
7
1
Target Price
$19.00
$14.00
AVG Volume (30 Days)
2.0M
725.5K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
$1,466,397,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.22
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$3.35
52 Week High
$9.57
$11.85

Technical Indicators

Market Signals
Indicator
CADL
RYAM
Relative Strength Index (RSI) 56.76 48.59
Support Level $4.80 $8.22
Resistance Level $9.42 $8.80
Average True Range (ATR) 0.57 0.34
MACD -0.09 -0.01
Stochastic Oscillator 37.35 56.58

Price Performance

Historical Comparison
CADL
RYAM

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc engaged in the production and sale of high-purity cellulose and other cellulose-based materials derived from renewable wood fiber. The company operates through five segments: Cellulose Specialties, which produces purified cellulose used in products such as filters, pharmaceuticals, food additives and electronics; Biomaterials, which produces products including biofuels, lignosulfonates and other bio-based chemicals; Cellulose Commodities, which manufactures absorbent and viscose pulp used in textiles and hygiene products; Paperboard, which produces coated paperboard used for packaging and printing applications; and High-Yield Pulp, which produces pulp used in paperboard, packaging and printing paper products.

Share on Social Networks: